New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GE;DELL;GSK;AZN;BEN;AAPL From The Last 14 Days
Check below for free stories on GE;DELL;GSK;AZN;BEN;AAPL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>
August 21, 2014
13:23 EDTAAPLWal-Mart cut iPhone prices, Washington Post says
Wal-Mart (WMT) today began selling Apple's (AAPL) iPhone 5s for $79, and cut the price of the iPhone 5c to just 97c, according to The Washington Post. The devices previously cost $99 and $29 respectively at Wal-Mart, the newspaper stated. Reference Link
11:44 EDTAAPLHP hits 52-week high after solid revenue growth, positive analyst commentary
Subscribe for More Information
10:34 EDTAAPLOptions Update; August 21, 2014
Subscribe for More Information
10:03 EDTAAPLActive puts at CBOE
Subscribe for More Information
10:02 EDTAAPLActive calls at CBOE; AAPL C HPQ
Active calls at CBOE; AAPL 8/22/14 100 & 100, C Jan 55, HPQ 8/29/14 36
09:54 EDTAZNPotential Pfizer, AstraZeneca deal seen around year-end, Reuters says
Investors and analysts see Pfizer (PFE) making another attempt to acquire AstraZeneca (AZN) around year-end, even though talks between the two can resume on August 26 per British takeover rules, Reuters reports. Reference Link
09:37 EDTAAPLActive equity options trading on open
Subscribe for More Information
07:47 EDTAZNPfizer looking at new targets, including Actavis, Bloomberg reports
While it weighs another attempt to acquire AstraZeneca (AZN), Pfizer is considering other overseas alternatives, including Actavis (ACT), Bloomberg reports, citing people familiar with the matter. Pfizer prefers to reach a deal with AstraZeneca, and a move on another company is unlikely "anytime soon," Bloomberg adds, citing its sources. Shares of Actavis are rising 3%, or $6.65, to $230.01 in pre-market trading, while AstraZeneca is up 2% to $72.59. Reference Link
05:42 EDTAZNIllumina announces strategic partnership with AstraZeneca, Sanofi, Janssen
Illumina (ILMN) announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing, or NGS,-based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection, resulting in a more comprehensive tool for precision medicine. Initial strategic partners include AstraZeneca (AZN), Janssen Biotech, a Johnson & Johnson (JNJ) company, and Sanofi (SNY). Illumina is working with the strategic partners to develop assays that detect and measure multiple variants simultaneously to support partners’ clinical trials, with the objectives of securing regulatory agency approvals and test commercialization. In parallel, Illumina is working with key thought leaders to set standards for NGS-based assays in routine clinical oncology practice, as well as to define regulatory frameworks to enable this new testing paradigm. Together, Illumina and its strategic partners aim to transition from single-analyte companion diagnostics to panel-based assays that select for “companion therapeutics.”
August 20, 2014
16:01 EDTAAPLOptions Update; August 20, 2014
Subscribe for More Information
15:35 EDTGSKGlaxoSmithKline receives FDA approval for Arnuity Ellipta in the U.S.
Subscribe for More Information
13:46 EDTAAPLVerizon looking to build app store, The Information says
Verizon (VZ) is looking to partner with other companies to build an app store, according to The Information. Verizon's app store would compete with Google (GOOG) and Apple (AAPL), which already sell smartphone software, The Information noted. Reference Link
11:44 EDTGSKMylan completes second bidding round for GSK prescription portfolio, WSJ says
Mylan (MYL), TPG Capital, Advent International, KKR (KKR), Warburg Pincus and a few Indian prescription manufacturers have completed the second round of bidding for GlaxoSmith Kline's (GSK) portfolio of mature medications, according to The Wall Street Journal, citing people familiar with the sales process. GSK noted that it aims to sell a portfolio of drug brands in the U.S. and EU with yearly sales of approximately $1.66B. Reference Link
11:15 EDTAAPLGT Advanced retreats after analyst downgrades stock
Shares of sapphire maker GT Advanced (GTAT) are falling after research firm CLSA downgraded the stock in a note to investors today. The firm cited concerns about increased costs associated with the company's deal with Apple as the main reason for the downgrade. WHAT'S NEW: GT Advanced's costs associated with its deal to supply sapphire to Apple are being impacted by low yields, CLSA analyst Mark Heller wrote after speaking with strategic consulting firm Yole Développement. Lower yields will reduce the amount of sapphire that GT Advanced can produce for Apple, and will negatively affect GT’s profit margins, explained Heller. He believes that GT Advanced's risk/reward ratio is balanced at current levels, and downgraded his rating on the shares to Underperform from Outperform. However, he raised his price target on the shares to $19 from $18. PRICE ACTION: In late morning trading, GT Advanced fell 2% to $18.
09:38 EDTAAPL, AAPLGT Advanced downgraded to Underperform from Outperform at CLSA
Subscribe for More Information
09:36 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL FOLD TSLA TWTR WHX FB TM NFLX X EOG
08:30 EDTGSKPernix closes acquisition of Treximet
Subscribe for More Information
08:29 EDTGSKPernix Therapeutics to host conference call
Conference call to discuss acquisition of Treximet will be held on August 20 at 9 am. Webcast Link
08:11 EDTGEGE Healthcare Life Sciences announces new U.S. headquarters in MA
Subscribe for More Information
08:04 EDTGSKPOZEN announces U.S. rights for Treximet acquired by Pernix Therapeutics
Subscribe for More Information
06:28 EDTAAPLApple could delay iWatch until 2015, FT Alphaville reports
Subscribe for More Information
August 19, 2014
17:31 EDTGEGE plans to invest $3.5B in aircraft engine unit, Nikkei says
General Electric plans to invest $3.5B in its aircraft engine business over the five years to 2017, as it looks to boost production, says Nikkei. Reference Link
17:14 EDTAAPLOn The Fly: Closing Wrap
Subscribe for More Information
16:00 EDTAAPLOptions Update; August 19, 2014eBay
iPath S&P 500 VIX Short-Term Futures down 28c to 27.52. Option volume leaders: AAPL C HD PBR GILD AA NFLX TWTR TSLA EBAY according to Track Data.
14:19 EDTAAPLCarl Icahn says increased Apple position over past year
Carl Icahn tweeted in regards to Apple, "All my chips still on the table and in fact increased position over past year." Icahn added that anyone who invested in Apple last year when he recommended the stock would be up 53% including dividends.
13:54 EDTAAPLCarney a contender to take over top communications job at Apple, Re/code says
Subscribe for More Information
12:40 EDTAAPLApple nears life high, levels to watch
Subscribe for More Information
12:27 EDTAAPLIcahn says 'very sizable' shareholder of Apple, has not sold share
Subscribe for More Information
11:57 EDTAAPLApple shares reach $100, up 84c or 1%
09:38 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GILD TSLA CELG VLO VZ FB HD
07:01 EDTAZNDOJ closes investigation into PLATO Brilinta clinical trial, plans no action
AstraZeneca today announced that it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical trial with BRILINTA tablets. The government is not planning any further action. Pascal Soriot, CEO, said: “We welcome the Department of Justice’s decision not to pursue further action. We have always had absolute confidence in the integrity of the PLATO trial and we are proud of the important benefit BRILINTA offers to patients around the world suffering from acute coronary syndrome. As one of AstraZeneca’s growth platforms, we remain committed to delivering the full potential of this important medicine.” As part of our continued commitment to advancing the science behind cardiovascular medicine, AstraZeneca has initiated a clinical trial program for BRILINTA, its largest program involving more than 80,000 patients worldwide.
06:32 EDTAAPLMorgan Stanley recommends adding to Apple positions
Subscribe for More Information
06:22 EDTGEGeneral Electric in talks with Electrolux to sell appliance business, WSJ says
Subscribe for More Information
August 18, 2014
16:00 EDTAAPLOptions Update; August 18, 2014
Subscribe for More Information
09:35 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL AMZN DG TSLA GILD FB ABX WFC C
08:30 EDTAAPLApple starts production of smartphones with sapphire screens, Guardian says
Subscribe for More Information
07:58 EDTAAPLApple December quarter EPS likely to beat by 10%+, says RBC Capital
Subscribe for More Information
07:57 EDTAZNCambridge Healthtech Institute to hold a summit
6th Annual Bioprocessing Summit to be held in Boston on August 18-22.
07:07 EDTGEGeneral Electric reinstated with an Outperform at Credit Suisse
Subscribe for More Information
06:42 EDTAAPLApple may call 5.5-inch iPhone '6L,' 9to5Mac reports
Apple may call its rumored 5.5-inch iPhone model the "6L," 9to5Mac reports, citing Asia-based rumor site Apple Daily. In this scenario, the 4.7-inch iPhone would be called the iPhone 6. Reference Link
05:23 EDTAAPLInvenSense downgraded to Neutral from Buy at Goldman
Goldman Sachs downgraded InvenSense (INVN) to Neutral citing valuation with shares near its $25 price target. Goldman also believes the near-term catalyst of share gains at Apple (AAPL) has passed. InvenSense closed Friday down 1c to $24.99.
August 17, 2014
18:38 EDTAAPLToo early to sell Apple, Barron's says
Subscribe for More Information
August 15, 2014
16:00 EDTAAPLOptions Update; August 15, 2014
iPath S&P 500 VIX Short-Term Futures up 1c to 28.88. Option volume leaders: AAPL GILD NFLX PBR TWTR TSLA MNKD AMZN C according to Track Data.
10:09 EDTAAPLSony expected to debut Smartwatch 3 next month, GigaOM reports
Subscribe for More Information
09:35 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:29 EDTAAPLChina Telecom now hosting Apple iCloud data in China, Marbridge Daily says
Apple (AAPL), which had previously been storing iCloud data for its Chinese users on servers in the U.S., in reportedly using China Telecom (CHA) as its sole cloud storage services provider in China, according to online Chinese media reports, said Marbridge Daily, citing Sina Tech. Apple and China Telecom have not commented, the report noted. Reference Link
06:34 EDTGSKLawyer says GSK connected investigators to not appeal ruling, Reuters says
Defense lawyer Zhai Jian said GlaxoSmithKline connected corporate investigator Peter Humphrey and his American wife are not aiming to appeal a Chinese court's prison sentence ruling, according to Reuters, citing comments from Jian. Reference Link
August 14, 2014
19:41 EDTAAPLApple considering sapphire glass in upcoming iPhone, smartwatch, WSJ reports
Subscribe for More Information
17:08 EDTAAPLSoros Fund Management gives quarterly update on stakes
NEW STAKES: CONSOL Energy (CNX), Google (GOOG), Level 3 (LVLT), Time Warner (TWC), and New Oriental (EDU). INCREASED STAKES: YPF SA (YPF), Apple (AAPL), Facebook (FB), AIG (AIG), and American Airlines (AAL). DECREASED STAKES: Teva (TEVA), Liberty Global (LBTYK), Barrick Gold (ABX), EQT (EQT), and Comcast (CMCSA). LIQUIDATED STAKES: FedEx (FDX), Monster Beverage (MNST), Google (GOOGL), Devon Energy (DVN), Marathon Petroleum (MPC).
17:00 EDTAAPLGreenlight Capital gives quarterly update on stakes
Subscribe for More Information
16:01 EDTAAPLOptions Update; August 14, 2014
Subscribe for More Information
14:13 EDTAAPLOmega Advisors gives quarterly update on stakes
Subscribe for More Information
13:26 EDTGEGE evaluating 'wide range' of options for appliances unit, Bloomberg reports
General Electric (GE) says it is evaluating a "wide range" of options for its home appliance business, Bloomberg reports. According to a GE spokesperson, the company is holding discussions with Electrolux (ELUXY) and other parties. Consumer development startup Quirky is also said to be interested in the GE unit. Reference Link
12:25 EDTGEGE says evaluating 'range' of options for Appliances, Bloomberg reports
General Electric confirmed in an interview that its in talks with Electrolux AB (ELUXY) regarding the potential sale of its Appliances unit, Bloomberg reports. GE added its evaluating a "wide range of strategic options" for its Appliances unit.
12:01 EDTAZNThird Point gives quarterly update on stakes
NEW STAKES: Rackspace (RAX), Finisar (FNSR), Amgen (AMGN), Ally Financial (ALLY), and AstraZeneca (AZN). INCREASED STAKES: Dollar General (DG) and Dow Chemical (DOW). DECREASED STAKES: FedEx (FDX), Hertz (HTZ), T-Mobile (TMUS) and Intrexon (XON). LIQUIDATED STAKES: Google Class A (GOOGL), Verizon (VZ) and Mondelez (MDLZ).
11:22 EDTGEElectrolux confirms in talks to acquire GE Appliances
Electrolux (ELUXY) confirmed that it is in discussions regarding a possible acquisition of the appliances business of GE (GE). "No agreement has been reached, and there can be no assurances that an agreement will be reached. Any further announcements will be made in due course," Electrolux stated.
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:11 EDTGEGE Healthcare to use RTI Connext Middleware
Subscribe for More Information
07:55 EDTAAPLApple bans two chemicals from iPhone, iPad final stages, AP says
Apple said its investigation at 22 factories found no evidence that two potentially hazardous chemicals, benzene and n-hexane, endangered the plants' workers, but the company is banning the use of those chemicals in the final assembly of iPhones and iPads, reported Associated Press, citing statements from the company. Apple is still allowing use of the two chemicals during the early production phases, but is lowering the maximum amount of benzene and n-hexane that can be present in the materials used during those phases. Reference Link
06:19 EDTAAPLLenovo sees opportunities outside of China for smartphone business, WSJ reports
Lenovo CEO Yang Yuanqing tells the Wall Street Journal that although that China is still the most important market for its smartphone business, the company sees additional opportunities outside China. Reference Link
August 13, 2014
20:04 EDTGEGE appliance unit drawing interest from Electrolux, Quirky, Bloomberg says
General Electric's home appliance unit has drawn interest from Electrolux and Quirky, according to Bloomberg, citing two people with knowledge of the matter. General Electric's appliance unit is said to be worth about $2B, the sources added. Reference Link
19:35 EDTGEGE appliance unit drawing interest from Electrolux, Quirky, Bloomberg says
Subscribe for More Information
16:19 EDTGSKOn The Fly: Closing Wrap
Subscribe for More Information
16:00 EDTAAPLOptions Update; August 13, 2014
Subscribe for More Information
13:13 EDTGSKInterMune exploring sale after bids from Sanofi, Roche, Glaxo, Bloomberg says
InterMune (ITMN) is working with its financial advisers Goldman Sachs (GS) and Centerview Partners to evaluate takeover bids it has received from Sanofi (SNY), Roche (RHHBY), GlaxoSmithKline (GSK) and Actelion (ALIOF), said Bloomberg, citing people with knowledge of the matter. The report noted that one of the sources said Sanofi has so far shown the most interest in a deal for InterMune, whose shares are up more than 13% to $51.56 following the first headlines from the report. Reference Link
11:41 EDTAAPLAmazon payment move complements e-commerce platform, says RW Baird
Baird said Amazon's (AMZN) launch of the "Local Register" payment and card reader system is not a surprise after the company's acquisition of assets from GoPago and that the move is complementary to Amazon's e-commerce platform. Baird said Amazon's system will compete with Square and eBay's (EBAY) payment product "Here" and added that it expects Google (GOOG) and Apple (AAPL) to expand their existing payment initiatives. The firm maintains its Outperform rating and $400 price target on Amazon.com.
09:37 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:31 EDTAZNAstraZeneca says Phase 3 trials of lesinurad for gout met primary endpoints
AstraZeneca announced top-line results from CLEAR1, CLEAR2 and CRYSTAL, the pivotal Phase III clinical trials investigating the potential of lesinurad, a selective uric acid re-absorption inhibitor, as a combination therapy for the treatment of patients with symptomatic gout. Lesinurad is an investigational agent that inhibits the URAT1 transporter, increasing uric acid excretion and thereby lowering serum uric acid. In the CLEAR1 and CLEAR2 trials, both lesinurad 200mg and 400mg in combination with allopurinol met the primary endpoint, with a statistically significant higher proportion of patients reaching the target sUA goal of <6.0mg/dL at month 6 compared to allopurinol alone. In the CRYSTAL trial, lesinurad 400mg in combination with febuxostat met the primary endpoint, with a statistically significant higher proportion of patients reaching the target sUA goal of <5.0mg/dL at month 6 compared to febuxostat alone. Although lesinurad 200mg did not achieve statistical significance at month 6, this dose in combination with febuxostat, was superior to placebo plus febuxostat at all other time points. Results from these Phase III clinical trials will be submitted to a scientific meeting later in 2014. The company is proceeding with preparation of regulatory submissions for lesinurad 200mg combination therapy.
07:19 EDTAAPLSiri creators working on new advanced AI system, Wired reports
Subscribe for More Information
August 12, 2014
16:00 EDTAAPLOptions Update; August 12, 2014
iPath S&P 500 VIX Short-Term Futures down 20c to 31.65. Option volume leaders: AAPL MNKD TWTR TSLA KMI KATE MGM NFLX KO according to Track Data.
09:35 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GOOG C TSL EXAS BAC DNDN JNJ TSLA
08:18 EDTGEAs MetLife awaits SIFI decision, other non-banks get tough scrutiny, FT says
The Federal Reserve's scrutiny of AIG (AIG) and GE Capital (GE) since those non-banks were designated as systemic risks shows they are being regarded in the same manner as large banks, according Financial Times, citing people familiar with the process. Insurer Prudential Financial (PRU) was deemed a systemic risk last September and rival MetLife (MET) is waiting to see if it will be designated this year, the report noted. Reference Link
07:15 EDTGSKWHO says ethical to offer unproven interventions in light of Ebola outbreak
Subscribe for More Information
06:24 EDTAAPLApple readies Healthkit launch despite complicated regulations, Reuters says
Subscribe for More Information
06:19 EDTAAPLApple suppliers begin production of next-generation iPads, Bloomberg says
Apple suppliers began production of next-generation iPads as the tech firm looks to reignite the popularity of tablet computers after it experienced two consecutive quarters of sales declines, according to Bloomberg, citing people with knowledge of the matter. Reference Link
06:18 EDTGSKGSK CEO faces pressure as company deals with weak sales, allegations, WSJ says
Subscribe for More Information
05:58 EDTAZNStocks with implied volatility movement; P AZN
Subscribe for More Information
05:47 EDTAAPLApple December quarter margins likely down sequentially, says Piper Jaffray
Piper Jaffray says it’s likely that Apple's December quarter margins decline quarter-over-quarter due to the impact of the updated iPhone 6. Piper does not view the potential margin decline as a long-term negative, however, noting that Apple showed with the iPhone 5S that margins can expand as the company moves away from new design launches. Piper says it remains a buyer of Apple shares with an Overweight rating and $105 price target.
August 11, 2014
17:44 EDTGEGeneral Electric awarded $311.49M government contract modification
General Electric is being awarded a $311.49M modification to a previously awarded firm-fixed-price contract for the procurement of 75 Lot 14 F/A-18E/F F414-GE-400 engines and associated devices for U.S. Navy and for the government of Australia. In addition, this modification provides for the procurement of after burner modules, fan modules, high pressure combustor modules, combustor modules, and high and low pressure turbine modules for the U.S. Navy and the government of Australia. Work will be performed in Lynn, Massachusetts; Hooksett, New Hampshire; Rutland, Vermont; and Madisonville, Kentucky, and is expected to be completed in September 2016. This modification combines purchases for the U.S. Navy and the government of Australia under the Foreign Military Sales Program. The Naval Air Systems Command, Patuxent River, Maryland, is the contracting activity.
16:50 EDTBENFranklin Resources announces $907.9B in assets under management at July 31
Subscribe for More Information
16:00 EDTAAPLOptions Update; August 11, 2014
iPath S&P 500 VIX Short-Term Futures down 1.33 to 31.90. Option volume leaders: AAPL KMI MNKD PBR AMZN SCTY TWTR TSLA according to Track Data.
12:57 EDTGSKGlaxoSmithKline facing new bribery allegations in Syria, Reuters reports
Subscribe for More Information
10:07 EDTAAPLVirnetX says court denies Apple motion in patent suit
VirnetX (VHC) announced that on August 8 the U.S. District Court for the Eastern District of Texas, Tyler Division, issued its patent claim construction, or "Markman" Order and ruled on a VirnetX motion in the ongoing patent infringement action between VirnetX and Apple (AAPL). Both parties had presented arguments on the disputed terms along with various other motions at a Markman hearing on May 20. In the Markman order, the court denied Apple's Motion for Summary Judgment of Indefiniteness, in which Apple alleged that some of the disputed claims terms in the patents asserted by VirnetX were invalid for indefiniteness. In a separate order, the court granted in part and denied in part VirnetX's Motion for Partial Summary Judgment on Apple's Invalidity Counterclaims. The court's order precludes Apple from asserting invalidity as a defense against infringement of the claims that were tried before a jury in VirnetX's prior litigation against Apple. Apple is not precluded from asserting invalidity as a defense against infringement of the claims that were not tried before a jury in the Apple I case. "We are extremely pleased with the court's rulings and we remain confident in the merits of our complaint against Apple," said Kendall Larsen, VirnetX CEO and President. "We believe the court's Markman Order and motion ruling represents another significant step towards the successful resolution of this litigation."
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:47 EDTGSKGlaxo to conduct Ebola vaccine trials later this year, Guardian says
Subscribe for More Information
06:23 EDTAAPLGoogle testing "Listen Now" music ads, WSJ reports
Subscribe for More Information
August 10, 2014
16:51 EDTAAPLCourt rejects $324M settlement in tech hiring conspiracy, NYT says
Subscribe for More Information
August 8, 2014
16:16 EDTAAPLU.S. judge rejects Apple, Google antitrust hiring accord, Bloomberg reports
Subscribe for More Information
16:00 EDTAAPLOptions Update; August 8, 2014
Subscribe for More Information
09:37 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:03 EDTGSKGlaxoSmithKline weakness creates buying opportunity, says Argus
Subscribe for More Information
07:31 EDTAAPLChina refutes report of Apple product procurement ban, Re/code reports
Subscribe for More Information
06:18 EDTGSKRoyal Bank of Scotland's Hampton leads race to become new GSK chair, FT reports
Royal Bank of Scotland (RBS) Chairman Philip Hampton is the frontrunner to succeed Christopher Gent as chairman of GlaxoSmithKline (GSK), the Financial Times reports, citing sources. Gent will step down from his role at GSK next year. Hampton is not expected to step down from RBS until after May's general election, the sources say. Reference Link
August 7, 2014
16:00 EDTAAPLOptions Update; August 7, 2014
Subscribe for More Information
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
06:43 EDTAAPLApple poaches YSL's Catherine Monier, 9to5Mac reports
Subscribe for More Information
06:19 EDTAAPLMicrosoft in talks to open Fifth Avenue store, Daily News reports
Subscribe for More Information
06:13 EDTAZNDynavax says AZD1419 Phase 1 study met secondary endpoints
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use